Seagen to Report First Quarter 2023 Financial Results on April 27, 2023

4/7/23 8:00:00 AM ET

Biotechnology: Biological Products (No Diagnostic Substances)

Health Care

Get the next $SGEN alert in real time by email

Seagen Inc. (NASDAQ:SGEN) today announced that it will report its first quarter 2023 financial results on Thursday, April 27, 2023.

Given the recently announced agreement to be acquired by Pfizer Inc., Seagen will not be hosting a conference call.

About Seagen

Seagen is a global biotechnology company that discovers, develops and commercializes transformative cancer medicines to make a meaningful difference in people's lives. Seagen is headquartered in the Seattle, Washington area, and has locations in California, Canada, Switzerland and the European Union. For more information on the company's marketed products and robust pipeline, visit www.seagen.com and follow @SeagenGlobal on Twitter.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230407005028/en/

Get the next $SGEN alert in real time by email

Date	Price Target	Rating	Analyst
2/16/2023	$140.00 → $175.00	In-line → Outperform	Evercore ISI
2/16/2023	$155.00 → $175.00	Outperform → Strong Buy	Raymond James
2/6/2023	$162.00 → $141.00	Outperform → Market Perform	SVB Securities
11/21/2022	$135.00	Hold	Truist
10/11/2022	$177.00 → $178.00	Market Perform → Outperform	BMO Capital Markets
6/29/2022	$220.00	Outperform	Raymond James
6/24/2022	$169.00	Market Perform	BMO Capital Markets
2/16/2022	$201.00 → $142.00	Market Outperform	JMP Securities

Seagen to Report First Quarter 2023 Financial Results on April 27, 2023

Chat with this insight

Recent Analyst Ratings for
$SGEN

$SGEN
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Baker Bros. Advisors Lp returned $10,248,908,740 worth of shares to the company (44,755,060 units at $229.00), closing all direct ownership in the company (SEC Form 4)

Himes Vaughn B returned $30,765,005 worth of shares to the company (134,345 units at $229.00), closing all direct ownership in the company (SEC Form 4)

Simonian Nancy A returned $14,370,437 worth of shares to the company (62,753 units at $229.00), closing all direct ownership in the company (SEC Form 4)

Seagen to Report First Quarter 2023 Financial Results on April 27, 2023

Chat with this insight

Recent Analyst Ratings for $SGEN

$SGEN Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Baker Bros. Advisors Lp returned $10,248,908,740 worth of shares to the company (44,755,060 units at $229.00), closing all direct ownership in the company (SEC Form 4)

Himes Vaughn B returned $30,765,005 worth of shares to the company (134,345 units at $229.00), closing all direct ownership in the company (SEC Form 4)

Simonian Nancy A returned $14,370,437 worth of shares to the company (62,753 units at $229.00), closing all direct ownership in the company (SEC Form 4)

Recent Analyst Ratings for
$SGEN

$SGEN
Insider Trading